Björn Nodin
91 – 100 of 120
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Associations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability
- Contribution to journal › Article
-
Mark
Reduced expression of ezrin in urothelial bladder cancer signifies more advanced tumours and an impaired survival: validatory study of two independent patient cohorts.
- Contribution to journal › Article
-
Mark
Expression and prognostic significance of the polymeric immunoglobulin receptor in esophageal and gastric adenocarcinoma.
- Contribution to journal › Article
-
Mark
Expression and prognostic significance of the polymeric immunoglobulin receptor in epithelial ovarian cancer
- Contribution to journal › Article
-
Mark
Prognostic and treatment predictive significance of SATB1 and SATB2 expression in pancreatic and periampullary adenocarcinoma
- Contribution to journal › Article
-
Mark
Incident urothelial cancer in the Malmö Diet and Cancer Study: cohort characteristics and further validation of ezrin as a prognostic biomarker.
- Contribution to journal › Article
- 2013
-
Mark
Sushi domain-containing protein 4 (SUSD4) inhibits complement by disrupting the formation of the classical C3 convertase.
- Contribution to journal › Article
-
Mark
Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer.
- Contribution to journal › Article
-
Mark
Clinicopathological correlates and prognostic significance of KRAS mutation status in a pooled prospective cohort of epithelial ovarian cancer
- Contribution to journal › Article
-
Mark
Sex differences in the prognostic significance of KRAS codons 12 and 13, and BRAF mutations in colorectal cancer: a cohort study
- Contribution to journal › Article
